Kindred Biosciences Inc
Most Recent
The Baupost Group ups its stake in Idenix Pharmaceuticals
Idenix Pharmaceuticals (IDIX) accounted for a 6.25% position in Baupost’s fourth quarter portfolio. The hedge fund increased its stock holdings in Idenix last month.
Seth Klarman’s Baupost Group raises its stake in PBF Energy
The Baupost Group raised its stake in PBF Energy Inc. (PBF) by 1,021,466 shares to own 1,976,606 shares at the end of the fourth quarter.
Seth Klarman’s Baupost Group buys stake in Kindred Biosciences
The Baupost Group opened a new position in animal health company Kindred Biosciences Inc. (KIN) that accounts for 0.92% of the fund’s $3.5 billion portfolio.
